| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.41B | +11.6% | +17.3% |
| Cost of Revenue | $174.9M | +12.8% | -35.2% |
| R&D Expense | $43.9M | -0.4% | -70.8% |
| SG&A Expense | $58.8M | +6.7% | +55.0% |
| Operating Income | $1.08B | +12.7% | +101.7% |
| Pre-tax Income | $1.02B | +15.5% | +118.3% |
| Income Tax | $185.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.67B | +39.8% | +193.7% |
| Accounts Receivable | $1.60B | +1.4% | +35.1% |
| Current Assets | $3.49B | +16.5% | +86.0% |
| Total Assets | $6.34B | +6.4% | +16.5% |
| Current Liabilities | $1.07B | -1.9% | +37.7% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.66B | — | — |
| Investing Cash Flow | $359.3M | — | — |
| Financing Cash Flow | -$2.10B | — | — |
| +65.3% |
| +457.6% |
| Net Income | $835.5M | +2.0% | +92.3% |
| EPS (Basic) | $2.47 | +2.1% | +91.5% |
| EPS (Diluted) | $2.45 | +2.5% | +96.0% |
| $3.51B |
| +0.0% |
| +1.1% |
| Total Liabilities | $4.87B | +1.6% | +8.1% |
| Stockholders' Equity | $1.47B | +26.3% | +57.1% |